Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Needle preference in patients receiving cosmetic botulinum toxin type A.

Publication ,  Journal Article
Price, KM; Williams, ZY; Woodward, JA
Published in: Dermatol Surg
2010

BACKGROUND: Patients often complain of pain and bruising from needle injections. Some clinicians believe smaller gauge needles cause less pain. Thirty-gauge needles are currently the standard needles employed for administering botulinum toxin type A (BTX-A). OBJECTIVE: This study sought to determine whether patients receiving BTX-A have a preference for 30-gauge or 32-gauge needles based on the amount of pain and bruising experienced. METHODS: Thirty-seven subjects received BTX-A on the right side of the face using a 30-gauge needle and on the left side using a 32-gauge needle. Subjects were masked to needle size. They were then asked to rate injection pain on an 11-point numerical rating scale and to note any bruising. Physician preference was also evaluated. RESULTS: There were no statistically significant differences in the amount of intra-procedural pain (p=.37) or the level of post-procedural pain and discomfort (p=.76) experienced. Twenty-seven percent of subjects reported greater bruising with the 32-gauge needle, versus 29.7% with the 30-gauge needle. The physician injector did not have a preference. Lastly, 83.8% of subjects did not detect a difference in BTX-A paralysis effect. CONCLUSION: We do not recommend using 32-gauge needles in place of 30-gauge needles for administering BTX-A.

Duke Scholars

Published In

Dermatol Surg

DOI

EISSN

1524-4725

Publication Date

2010

Volume

36

Issue

1

Start / End Page

109 / 112

Location

United States

Related Subject Headings

  • Single-Blind Method
  • Patient Satisfaction
  • Patient Acceptance of Health Care
  • Pain Measurement
  • Pain
  • Neuromuscular Agents
  • Needles
  • Injections, Intramuscular
  • Humans
  • Dermatology & Venereal Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Price, K. M., Williams, Z. Y., & Woodward, J. A. (2010). Needle preference in patients receiving cosmetic botulinum toxin type A. Dermatol Surg, 36(1), 109–112. https://doi.org/10.1111/j.1524-4725.2009.01391.x
Price, Kristina M., Zinaria Y. Williams, and Julie A. Woodward. “Needle preference in patients receiving cosmetic botulinum toxin type A.Dermatol Surg 36, no. 1 (2010): 109–12. https://doi.org/10.1111/j.1524-4725.2009.01391.x.
Price KM, Williams ZY, Woodward JA. Needle preference in patients receiving cosmetic botulinum toxin type A. Dermatol Surg. 2010;36(1):109–12.
Price, Kristina M., et al. “Needle preference in patients receiving cosmetic botulinum toxin type A.Dermatol Surg, vol. 36, no. 1, 2010, pp. 109–12. Pubmed, doi:10.1111/j.1524-4725.2009.01391.x.
Price KM, Williams ZY, Woodward JA. Needle preference in patients receiving cosmetic botulinum toxin type A. Dermatol Surg. 2010;36(1):109–112.
Journal cover image

Published In

Dermatol Surg

DOI

EISSN

1524-4725

Publication Date

2010

Volume

36

Issue

1

Start / End Page

109 / 112

Location

United States

Related Subject Headings

  • Single-Blind Method
  • Patient Satisfaction
  • Patient Acceptance of Health Care
  • Pain Measurement
  • Pain
  • Neuromuscular Agents
  • Needles
  • Injections, Intramuscular
  • Humans
  • Dermatology & Venereal Diseases